Prevalent Form of Childhood Leukemia May Be Preventable

Early exposure to common microbes could stop leukemia from manifesting in children.

Written bySukanya Charuchandra
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, FATCAMERAAn analysis of more than 30 years of research has revealed the underlying cause of the most common form of leukemia in children. Research compiled in Nature Reviews Cancer on May 21 suggests that acute lymphoblastic leukemia (ALL) occurs by a two-step process—first, a mutation occurs in the fetus and a second mutation, later in life and triggered by infection, spurs the cancer to develop.

“The most important implication is that most cases of childhood leukemia are likely to be preventable,” Melvyn Greaves, a cancer biologist at the Institute of Cancer Research in the U.K. and the author of the paper, says in a statement.

Only 1 percent of children born with an ALL-related mutation go on to have the disease. The ones who do have had little experience with common infections such as the flu in their formative years, according to Greaves. This lack of immune priming predisposes them to a genetic change caused by a later infection and, ultimately, causes the disease, Greaves proposes in his paper.

Greaves collated research from the fields of genetics, cell biology, immunology, and epidemiology. Further, experiments in mice support his conclusions. Mice ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control